Nucleic acid-based aptasensors for cancer diagnostics - An insight into immobilisation strategies

Pawan Jolly, Marina Batistuti, Serife Ustuner, Marcelo Mulato, Sunil Arya, Pedro Estrela

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Whilst antibodies remain the most popular and trusted choice for molecular recognition, they may still pose challenges for biosensing applications due to their high cost, low reproducibility and large size. One long championed alternative to antibodies are nucleic acid aptamers. Nucleic acid aptamers are single-stranded DNA or RNA sequences that can bind to a target with high affinity and specificity. Nucleic acid aptamers, due to their varied advantages, have been gaining significant importance in both diagnostic and theranostic applications. Among various diseases, early diagnosis of cancer is one of the biggest concerns for patients and healthcare professionals worldwide. For the case of cancer, it is crucial to be able to deliver treatment whilst monitoring therapy response in real time. This is required in order to prevent over- or under-dosing the patients whilst treatment occurs. One of the most commonly used techniques for cancer diagnosis is to detect biomarkers (cancer-related proteins, small molecules and cancer cells) found in body fluids specific for a particular cancer type. In this chapter, we present a discussion on the use of aptamer-based biosensors (termed as “aptasensors”) for cancer diagnosis. The development of aptamer-based biosensor devices is an interdisciplinary field and relies on very distinct aspects such as characterisation of bio-recognition probes with their respective analytes, immobilisation onto electrode surfaces, development of anti-fouling surface chemistries, sensor design and fabrication and microfluidics. Special attention is given to different types of surface chemistry used for the development of simple, sensitive and cost-effective aptasensors. Utilisation of aptamers is an encouraging tool for the development of point-of-care (PoC) biosensors for the detection of different types of cancer. In the view of unparalleled merits of aptamers, recent achievements and future perspectives of the applications of aptamers are also discussed.
LanguageEnglish
Title of host publicationNext generation point-of-care biomedical sensors technologies for cancer diagnosis
EditorsPranjal Chandra, Yen Nee, Surinder Singh
Place of PublicationSingapore
PublisherSpringer
Pages205-231
Number of pages27
ISBN (Electronic)978-981-10-4726-8
ISBN (Print)978-981-10-4725-1
DOIs
StatusPublished - Dec 2017

Fingerprint

Biosensors
Nucleic Acids
Surface chemistry
Patient treatment
Molecular recognition
Antibodies
Single-Stranded DNA
Body fluids
Tumor Biomarkers
Fouling
Microfluidics
Costs
Cells
RNA
Fabrication
Electrodes
Molecules
Monitoring
Sensors
Proteins

Keywords

  • Biosensors

Cite this

Jolly, P., Batistuti, M., Ustuner, S., Mulato, M., Arya, S., & Estrela, P. (2017). Nucleic acid-based aptasensors for cancer diagnostics - An insight into immobilisation strategies. In P. Chandra, Y. Nee, & S. Singh (Eds.), Next generation point-of-care biomedical sensors technologies for cancer diagnosis (pp. 205-231). Singapore: Springer. https://doi.org/10.1007/978-981-10-4726-8_9

Nucleic acid-based aptasensors for cancer diagnostics - An insight into immobilisation strategies. / Jolly, Pawan; Batistuti, Marina; Ustuner, Serife; Mulato, Marcelo; Arya, Sunil; Estrela, Pedro.

Next generation point-of-care biomedical sensors technologies for cancer diagnosis. ed. / Pranjal Chandra; Yen Nee; Surinder Singh. Singapore : Springer, 2017. p. 205-231.

Research output: Chapter in Book/Report/Conference proceedingChapter

Jolly, P, Batistuti, M, Ustuner, S, Mulato, M, Arya, S & Estrela, P 2017, Nucleic acid-based aptasensors for cancer diagnostics - An insight into immobilisation strategies. in P Chandra, Y Nee & S Singh (eds), Next generation point-of-care biomedical sensors technologies for cancer diagnosis. Springer, Singapore, pp. 205-231. https://doi.org/10.1007/978-981-10-4726-8_9
Jolly P, Batistuti M, Ustuner S, Mulato M, Arya S, Estrela P. Nucleic acid-based aptasensors for cancer diagnostics - An insight into immobilisation strategies. In Chandra P, Nee Y, Singh S, editors, Next generation point-of-care biomedical sensors technologies for cancer diagnosis. Singapore: Springer. 2017. p. 205-231 https://doi.org/10.1007/978-981-10-4726-8_9
Jolly, Pawan ; Batistuti, Marina ; Ustuner, Serife ; Mulato, Marcelo ; Arya, Sunil ; Estrela, Pedro. / Nucleic acid-based aptasensors for cancer diagnostics - An insight into immobilisation strategies. Next generation point-of-care biomedical sensors technologies for cancer diagnosis. editor / Pranjal Chandra ; Yen Nee ; Surinder Singh. Singapore : Springer, 2017. pp. 205-231
@inbook{991ebb7d308b41bd8224c18e8e430415,
title = "Nucleic acid-based aptasensors for cancer diagnostics - An insight into immobilisation strategies",
abstract = "Whilst antibodies remain the most popular and trusted choice for molecular recognition, they may still pose challenges for biosensing applications due to their high cost, low reproducibility and large size. One long championed alternative to antibodies are nucleic acid aptamers. Nucleic acid aptamers are single-stranded DNA or RNA sequences that can bind to a target with high affinity and specificity. Nucleic acid aptamers, due to their varied advantages, have been gaining significant importance in both diagnostic and theranostic applications. Among various diseases, early diagnosis of cancer is one of the biggest concerns for patients and healthcare professionals worldwide. For the case of cancer, it is crucial to be able to deliver treatment whilst monitoring therapy response in real time. This is required in order to prevent over- or under-dosing the patients whilst treatment occurs. One of the most commonly used techniques for cancer diagnosis is to detect biomarkers (cancer-related proteins, small molecules and cancer cells) found in body fluids specific for a particular cancer type. In this chapter, we present a discussion on the use of aptamer-based biosensors (termed as “aptasensors”) for cancer diagnosis. The development of aptamer-based biosensor devices is an interdisciplinary field and relies on very distinct aspects such as characterisation of bio-recognition probes with their respective analytes, immobilisation onto electrode surfaces, development of anti-fouling surface chemistries, sensor design and fabrication and microfluidics. Special attention is given to different types of surface chemistry used for the development of simple, sensitive and cost-effective aptasensors. Utilisation of aptamers is an encouraging tool for the development of point-of-care (PoC) biosensors for the detection of different types of cancer. In the view of unparalleled merits of aptamers, recent achievements and future perspectives of the applications of aptamers are also discussed.",
keywords = "Biosensors",
author = "Pawan Jolly and Marina Batistuti and Serife Ustuner and Marcelo Mulato and Sunil Arya and Pedro Estrela",
year = "2017",
month = "12",
doi = "10.1007/978-981-10-4726-8_9",
language = "English",
isbn = "978-981-10-4725-1",
pages = "205--231",
editor = "Pranjal Chandra and Yen Nee and Surinder Singh",
booktitle = "Next generation point-of-care biomedical sensors technologies for cancer diagnosis",
publisher = "Springer",

}

TY - CHAP

T1 - Nucleic acid-based aptasensors for cancer diagnostics - An insight into immobilisation strategies

AU - Jolly, Pawan

AU - Batistuti, Marina

AU - Ustuner, Serife

AU - Mulato, Marcelo

AU - Arya, Sunil

AU - Estrela, Pedro

PY - 2017/12

Y1 - 2017/12

N2 - Whilst antibodies remain the most popular and trusted choice for molecular recognition, they may still pose challenges for biosensing applications due to their high cost, low reproducibility and large size. One long championed alternative to antibodies are nucleic acid aptamers. Nucleic acid aptamers are single-stranded DNA or RNA sequences that can bind to a target with high affinity and specificity. Nucleic acid aptamers, due to their varied advantages, have been gaining significant importance in both diagnostic and theranostic applications. Among various diseases, early diagnosis of cancer is one of the biggest concerns for patients and healthcare professionals worldwide. For the case of cancer, it is crucial to be able to deliver treatment whilst monitoring therapy response in real time. This is required in order to prevent over- or under-dosing the patients whilst treatment occurs. One of the most commonly used techniques for cancer diagnosis is to detect biomarkers (cancer-related proteins, small molecules and cancer cells) found in body fluids specific for a particular cancer type. In this chapter, we present a discussion on the use of aptamer-based biosensors (termed as “aptasensors”) for cancer diagnosis. The development of aptamer-based biosensor devices is an interdisciplinary field and relies on very distinct aspects such as characterisation of bio-recognition probes with their respective analytes, immobilisation onto electrode surfaces, development of anti-fouling surface chemistries, sensor design and fabrication and microfluidics. Special attention is given to different types of surface chemistry used for the development of simple, sensitive and cost-effective aptasensors. Utilisation of aptamers is an encouraging tool for the development of point-of-care (PoC) biosensors for the detection of different types of cancer. In the view of unparalleled merits of aptamers, recent achievements and future perspectives of the applications of aptamers are also discussed.

AB - Whilst antibodies remain the most popular and trusted choice for molecular recognition, they may still pose challenges for biosensing applications due to their high cost, low reproducibility and large size. One long championed alternative to antibodies are nucleic acid aptamers. Nucleic acid aptamers are single-stranded DNA or RNA sequences that can bind to a target with high affinity and specificity. Nucleic acid aptamers, due to their varied advantages, have been gaining significant importance in both diagnostic and theranostic applications. Among various diseases, early diagnosis of cancer is one of the biggest concerns for patients and healthcare professionals worldwide. For the case of cancer, it is crucial to be able to deliver treatment whilst monitoring therapy response in real time. This is required in order to prevent over- or under-dosing the patients whilst treatment occurs. One of the most commonly used techniques for cancer diagnosis is to detect biomarkers (cancer-related proteins, small molecules and cancer cells) found in body fluids specific for a particular cancer type. In this chapter, we present a discussion on the use of aptamer-based biosensors (termed as “aptasensors”) for cancer diagnosis. The development of aptamer-based biosensor devices is an interdisciplinary field and relies on very distinct aspects such as characterisation of bio-recognition probes with their respective analytes, immobilisation onto electrode surfaces, development of anti-fouling surface chemistries, sensor design and fabrication and microfluidics. Special attention is given to different types of surface chemistry used for the development of simple, sensitive and cost-effective aptasensors. Utilisation of aptamers is an encouraging tool for the development of point-of-care (PoC) biosensors for the detection of different types of cancer. In the view of unparalleled merits of aptamers, recent achievements and future perspectives of the applications of aptamers are also discussed.

KW - Biosensors

U2 - 10.1007/978-981-10-4726-8_9

DO - 10.1007/978-981-10-4726-8_9

M3 - Chapter

SN - 978-981-10-4725-1

SP - 205

EP - 231

BT - Next generation point-of-care biomedical sensors technologies for cancer diagnosis

A2 - Chandra, Pranjal

A2 - Nee, Yen

A2 - Singh, Surinder

PB - Springer

CY - Singapore

ER -